Skip to main content

Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Director, Pharmacy Cancer Care, and Assistant Professor of Pharmacy, Mayo Clinic, Rochester, MN; HOPA Past President, 2016-2017
Director, Pharmacy Cancer Care, and Assistant Professor of Pharmacy, Mayo Clinic, Rochester, MN; HOPA Past President, 2016-2017

Authored Items

Adoption of Biosimilars—Why the Delay?
By Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
January 2023 Vol 16, No 1
Biosimilars
Biosimilars have been available in the United States for more than 5 years, and in Europe for more than 15 years, yet we still see reluctance in the adoption of these drugs. Read More ›